A carregar...
Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
The molecular events leading to gastroenteropancreatic neuroendocrine tumor (GEP-NET) formation are largely unknown. Over the past decades, systemic chemotherapies have been replaced by therapies directed at particular molecular targets such as the somatostatin receptors, mTOR complexes or proangiog...
Na minha lista:
| Publicado no: | Front Endocrinol (Lausanne) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722794/ https://ncbi.nlm.nih.gov/pubmed/29255447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00341 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|